A single institution's experience (1982-1999) with plasma-exchange therapy in patients with fulminant hepatic failure

International Journal of Artificial Organs

Volumn 23, Issue 7, 2000, Pages 454-461

  De Silvestro, G ^a   Marson, P ^a   Brandolese, R ^a   Pittoni, G ^a   Ongaro, G ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Fulminant hepatic failure; Lymphocyte subpopulations; Orthotopic liver transplantation; Outcome; Plasma exchange; Predictive factors

Indexed keywords

LYMPHOCYTES; PATIENT TREATMENT; POPULATION STATISTICS;

ACUTE VIRAL HEPATITIS; CONDITION; FULMINANT HEPATIC FAILURES; INTENSIVE CARE; LYMPHOCYTE SUBPOPULATION; MORTALITY RATE; ORTHOTOPIC LIVER TRANSPLANTATION; OUTCOME; PLASMA EXCHANGES; PREDICTIVE FACTORS;

DIAGNOSIS;

3,4 METHYLENEDIOXYMETHAMPHETAMINE; COCAINE; ISONIAZID; PARACETAMOL; PHENYTOIN; PROPYLTHIOURACIL; VALPROIC ACID;

ADOLESCENT; ADULT; AGED; AMANITA PHALLOIDES; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FUNCTIONAL RESIDUAL CAPACITY; HEPATITIS B VIRUS; HUMAN; INTENSIVE CARE; LIVER FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PLASMAPHERESIS; PROGNOSIS; PROTHROMBIN TIME; SURVIVAL RATE; TREATMENT OUTCOME; VIRUS HEPATITIS;

EID: 0033892735     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880002300708     Document Type: Article

References (33)

1. Critical care apheresis: Hepatic failure
2. Hepatite fulminante et subfulminante
3. Conventional care of fulminant hepatic failure: Medical and surgical aspects
4. Cause and prognosis in acute liver failure
5. Liver disease due to illicit substance use
6. Fulminat hepatic failure: Pathophysiology, treatment and survival
7. Fulminant hepatic failure
8. La terapia dell'insufficienza epatica. Nuove frontiere
9. Removal of endotoxin and cytokines by plasma-exchange in patients with acute hepatic failure
10. Effect of plasma-exchange on serum tissue inhibitor of metalloproteinase 1 and cytokine concentrations in patients with fulminant hepatitis
11. Extracorporeal blood purification in the management of patients with hepatic failure
12. Exchange-transfusion in hepatic coma: Report of a case
13. Plasmapheresis with plasma-exchange in hepatic coma
14. Plasmapheresis with plasma-exchange in hepatic coma
15. Liver assist systems: State of the art
16. Overview of extracorporeal liver support systems and clinical results
17. The management of fulminant hepatic failure
18. Acute hepatic necrosis with stupor or coma. An analysis of thirty-one patients
19. Fulminant hepatitis: Mayo Clinic experience with 34 cases
20. A double-blinded, randomized trail of hydrocortisone in acute hepatic failure
21. Extracorporeal methods of liver failure treatment
22. Efficacy and limitations of plasma-exchange in patients with acute hepatic failure: Comparing with hemoadsorption, and with impaired regeneration syndrome
23. High-volume plasmapheresis and acute liver transplantation in fulminant hepatic failure
24. Emergency liver transplantation for acute liver failure
25. When should a decision to proceed with transplantation actually be made in cases of fulminat or subfulminat hepatic failure: At admission to hospital or when a donor organ is made available?
26. Early indicators of prognosis in fulminant hepatic failure
27. Serial prothrombin time as prognostic indicator in acetaminophen-induced fulminant hepatic failure
28. Coagulation factor V and VII/V ratio as predictors of outcome in paracetamol-induced fulminant hepatic failure: Relation with other prognostic indicators
29. Predicting survival in fulminant hepatic failure using serum Gc protein concentrations
30. Fulminant hepatic failure. Observation with serial CT
31. The role of transjugular liver biopsy in fulminant liver failure: Relation to other prognostic indicators
32. Eitology and outcome for 295 patients with acute liver failure in the United States
33. Fulminant hepatitis due to Epstein-Barr virus infection